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Abstract - In the present study we examined gross changes in the mass of whole adrenal glands and that of the adrenal 
cortex, as well as the serum corticosterone and glucose level of mature male Wistar rats subjected to three different 
treatments: animals subjected to chronic restraint-stress, animals injected with lithium (Li) and chronically stressed rats 
treated with Li. Under all three conditions we observed hypertrophy of whole adrenals, as well as the adrenal cortices. 
Chronic restraint stress, solely or in combination with Li treatment, significantly elevated the corticosterone level, but 
did not change the blood glucose level. Animals treated only with Li exhibited an elevated serum corticosterone level 
and blood glucose level. The aim of our study was to investigate the modulation of the chronic stress-induced effect on 
the blood glucose level by lithium, as a possible mechanism of avoiding the damage caused by chronic stress. Our results 
showed that lithium is an agent of choice which may help to reduce stress-elevated corticosterone and replenish 
exhausted glucose storages in an organism. 
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INTRODUCTION 
Stress is a state of disturbed homeostasis due to 
internal or external sources such as physical or 
psychological stimuli known as stressors. The main 
physiological response to a stressor is the activation 
of the sympatho-adrenomedullary (SAS) and 
hypothalamic-pituitary-adrenal (HPA) systems, 
which can lead to an enhanced release of catecho-
lamines (CATs) and glucocorticoids (GCs) (Joels et 
al., 2007; Herman et al., 2003). The adaptive 
response of an organism is triggered by the stress-
induced elevation of serum GCs which regulate 
glucose metabolism including the stimulation of 
liver gluconeogenesis. The elevated blood glucose 
level provides the energy necessary for stress 
response (McKay and Cidlowski, 2000). Prolonged 
exposure to a stressor could compromise the adap-
tive response to stress and such conditions could 
exacerbate many mood disorders like anxiety, 
depression and bipolar disorders. In recent years, 
animal models have been developed that use a dif-
ferent chronic stress paradigm to induce neuro-
endocrine and central nervous system changes 
similar to those occurring in the course of the deve-
lopment of the mentioned pathologies (De Kloet et 
al., 2005; Machado-Vieira et al., 2004). One such 
model is chronic restraint stress, shown to induce 
the activation of the HPA axis and increase plasma 
corticosterone in certain rat strains (Uchida et al., 
2008). Similar prolonged GCs elevation as a result 
of HPA axis hyperactivity in humans may have a 
central role in the pathophysiology of mood disor-
ders (Watson and Mackin, 2006) and such 
conditions are successfully treated with lithium. In 
addition to that, lithium, an effective drug for both 
the treatment and prophylaxis of bipolar disorder, 
is also suggested to stimulate both the adrenome-
dullary and adrenocortical functions in rats 
(Chaudhuri-Sengupta et al., 2003; Ghosh et al., 
1990). Although lithium acts through the 
hypothalamic pathway (Spencer et al., 2005), its 
mechanism of action at the level of secretion of GCs 
has not been well defined. Since in normal rats 
lithium administration causes a rise in plasma 
glucose, which is a major biomarker of GCs action 
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(Fontela et al., 1986), it is also of interest to 
determine lithium action regarding this parameter 
under chronic stress.  
Based on these presumptions it was of interest 
to investigate the potential effects of lithium 
administration regarding both GCs and glucose in 
naive and Wistar male rats subjected to chronic 
restraint as a long-term stress model. 
MATERIALS AND METHODS 
Materials 
The OCTEIA Corticosterone EIA kit was purchased 
from Immunodiagnostic Systems Inc. (IDS Inc.) 
Fountain Hills, AZ, USA. Accutrend strips for 
determination of blood glucose were purchased 
from Roche Diagnostics GmbH, Mannheim, 
Germany. Lithium chloride (LiCl) was purchased 
from Sigma Chemical Company, St. Louis, USA.  
Animals and experimental protocol 
Male Wistar rats (3 months old) weighing 330-400 
g were housed under standard laboratory 
conditions at a temperature of (20 ± 2oC) with a 
natural 12-h light/dark cycle and free access to 
standard pellet chow and drinking water ad libitum. 
All experimental procedures were carried out 
within the light period of the light/dark cycle. The 
experimental protocol was in strict accordance with 
regulations and prescribed animal ethical 
procedures outlined by the Ethical Committee for 
the Use of Laboratory Animals of the Vinča 
Institute of Nuclear Sciences in accordance with the 
guidelines of the EU FELASA-registered Serbian 
Laboratory Animal Science Association (SLASA). 
All animals were habituated to maintenance 
conditions for a week prior to the experimental 
manipulations. During this time, they were 
randomly assigned to weight-matched groups of 12 
animals each. The following groups were con-
stituted: I - control (untreated) group (Ctrl); II - 
animals subjected to chronic restraint stress (Res); 
III - animals injected with LiCl (Li) and IV - 
chronically stressed rats with Li given each day 
immediately prior to daily restraint (Res+Li).  
Restraint stress was performed by placing each 
animal in a 25 x 7 cm plastic bottle as described 
previously (Gamaro et al., 1999). Animals in these 
groups were exposed to 2h of restraint stress every 
day at random times during the light period of the 
light/dark cycle to avoid habituation during the 
experimental procedure of 14 days (Kim and Han, 
2006). 
Lithium was administered intraperitoneally (IP) 
to the animals, once a day for 14 days as described 
previously (Nonaka and Chuang, 1998). The initial 
lithium dose was 1.5 mEq/kg for 2 days, and was 
then increased to 2.3 mEq/kg for 7 days followed by 
3 mEq/kg for 5 days. This lithium administration 
protocol maintained the plasma lithium concentra-
tion above the minimal therapeutic concentration 
(i.e. 0.4 mM) for the treatment of bipolar disorder 
throughout the treatment period. 
To reduce variance in the physiological para-
meters due to daily rhythms, all animals were 
sacrificed at the same time point in the circadian 
cycle, between 9:00 and 11:00 am, i.e., one day after 
the last treatments. Animals were sacrificed under 
no-stress conditions by rapid decapitation. 
Preparation of serum and determination of 
corticosterone and glucose concentration 
Blood from each animal was collected at the time of 
sacrifice. Serum was prepared by 15-min 
centrifugation at 3000 rpm. The corticosterone 
(CORT) level was determined by using the 
OCTEIA Corticosterone EIA kit according to the 
manufacturer’s instructions (Immunodiagnostic 
Systems Inc.). Calibrators, controls and diluted 
samples were loaded in duplicates on a 96-well plate 
coated with a polyclonal anti-CORT antibody, 
along with HRP-labeled CORT. The plate was 
incubated overnight at 4°C, washed, and color was 
developed using a chromogenic substrate. The 
reaction was stopped by adding HCl and the 
absorbance at 450 nm (reference 650 nm) was 
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Figure 1. Changes in the adrenal gland mass induced by 
chronic-stress and lithium treatment in male Wistar rats. The 
mass of the left (A) and right (B) adrenal gland are presented as 
means ± SEM; n = 12 in each experimental group [control 
(Ctrl), subjected to restraint stress (Res), injected with LiCl (Li) 
and stressed rats with Li given prior to restraint (Res+Li)]. 
Differences are statistically significant at *p<0.05, **p<0.01, and 
***p<0.001 (*treatment vs. control). 
determined with a microplate reader (Wallac, 
VICTOR2 1420, PerkinElmer). The concentration 
of CORT (ng/ml) was determined using a standard 
curve. For determination of glucose (GLU) 
concentration, a drop of fresh blood from each 
animal was applied to an Accutrend strip and 
assayed colorimetrically with an Accutrend GCT 
reader (Roche, Mennheim, Germany). 
Preparation of adrenal tissues and determination of 
their mass 
After sacrifice, the adrenal glands were carefully 
excised in situ and placed on an ice bath. The mass 
of the right or left gland was determined by 
weighing with a Mettler AE 50 electronic analytical 
balance having a precision of 0.1 mg (Mettler, 
Toledo, OH, USA). The following procedures were 
all carried on ice-cold Petri dishes placed in the ice-
bath. The adrenal cortices were carefully peeled off 
and completely removed and the remaining medul-
las were weighed using the Mettler electronic ana-
lytical balance. The mass of each adrenal cortex was 
calculated by subtracting the mass of the respective 
medulla from the total mass of the adrenal gland. 
Statistical analysis of data 
Data are presented as means ± SEM from 12 
animals per group. In order to establish significant 
differences between the control and treated ani-
mals, data were analyzed by one-way ANOVA. Va-
lues were considered statistically significant if the p 
value was less than 0.05. 
RESULTS 
Chronic-restraint stress and lithium treatment 
increase the adrenal gland mass in male Wistar 
rats. Adrenal gland masses were determined in 4 
experimental groups of 3-month-old Wistar male 
rats: I - control (untreated) group; II - animals 
subjected to chronic restraint stress; III - animals 
injected with Li and IV - chronically stressed rats 
treated with Li (see Methods section). As shown in 
Fig. 1 (A and B) the mass of the adrenal glands 
(both left and right) were significantly increased in 
the treated animals (II, III and IV) compared to 
controls (**p<0.01; ***p<0.001).  
The effects of both chronic-restraint stress 
and lithium treatment on the adrenal cortex 
mass. Changes in the adrenal cortex mass, the main 
source of serum corticosterone, were determined 
for both the left and right gland. The results 
presented in Fig. 2 (A and B) revealed a significant 
increment in the mass of both the left and right 
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Figure 2. Changes in the mass of adrenal cortex induced by
chronic-stress and lithium treatment in male Wistar rats. The
cortical mass of the left (A) and right (B) adrenal gland are 
presented as means ± SEM; n = 12 in each experimental group
[control (Ctrl), subjected to restraint stress (Res), injected with 
LiCl (Li) and stressed rats with Li given prior to restraint
(Res+Li)]. Differences are statistically significant at *p<0.05,
**p<0.01, and ***p<0.001 (*treatment vs. control). 
adrenal cortex in all treated groups in respect to the 
control (**p<0.01; ***p<0.001).  
Changes in serum corticosterone levels were not 
followed by changes in blood glucose in chronically 
stressed rats. Chronic restraint stress, solely or in 
combination with Li treatment, significantly elevated 
the corticosterone level (**p<0.01; *p<0.05), but did 
not change the blood glucose level (Fig. 3 A and B). 
Animals treated only with Li exhibited an elevated 
serum corticosterone level, as well as blood glucose 
level (*p<0.05) (Fig. 3 A and B). 
DISCUSSION 
Stress produces an endocrine and metabolic res-
ponse leading to a quick adaptation of the animal 
to a novel situation. A strong feature of the 
endocrine response to stress is the increase of the 
corticosterone (CORT) level. Long-term expo-
sure to glucocorticoids has been associated with 
several metabolic disorders, including fasting 
hyperglycemia and impaired glucose tolerance 
(Munck, 1971; Doyle et al., 1994; Horner et al., 
1990). Therefore, it was of interest to analyze the 
potential effects of lithium administration regar-
ding both GCs and glucose in naive and Wistar 
male rats subjected to chronic restraint as a long-
term stress model. 
Our experimental data indicated that animals 
subjected to chronic restraint stress exhibited in-
creased CORT level. This was not unexpected since 
it has been previously reported that this type of 
stress induces CORT secretion (Kim and Han, 
2006; Uchida et al., 2008). This result is in accor-
dance with enlarged adrenal glands (Tuli et al., 
1995), especially the cortex, found under this con-
dition (Figs. 1 and 2). In previous reports from 
other authors (Adzic et al., 2009) the difference in 
size between the left and right glands was reported 
under a different type of chronic stress, but under 
restraint stress this difference was observed only as 
a trend, without statistical significance. Although it 
is well known that GCs induce liver gluconeo-
genesis resulting in elevated blood glucose (McKay 
and Cidlowski, 2000), the results obtained from our 
model system indicated that prolonged exposure to 
high GCs was not accompanied with the expected 
increase in blood glucose (GLU) level. The plasma 
glucose concentration increased significantly du-
ring acute restraint stress in male Wistar rats, but 
after exposure to repeated restraint, there was no 
difference between the control and stressed groups 
when the plasma glucose level was measured 24 h 
after the last restraint session (Torres et al., 2001). 
This observation may perhaps be explained to be 
due to exhaustion of metabolic pools serving to 
generate glucose.  
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Figure 3. Changes in corticosterone and glucose levels induced
by chronic-stress and lithium treatment in male Wistar rats.
Serum levels of corticosterone and blood levels of glucose are
presented as means ± SEM; n = 12 in each experimental group
[control (Ctrl), subjected to restraint stress (Res), injected with
LiCl (Li) and stressed rats with Li given prior to restraint
(Res+Li)]. Differences are statistically significant at *p<0.05,
**p<0.01, and ***p<0.001 (*treatment vs. control). 
When lithium was administered to the control 
animals, it induced an increase in the adrenal glands 
mass (Fig. 1), serum CORT and blood GLU levels (Fig. 
3). Taking into account that lithium is implicated in the 
regulation of the adrenocortical functions in rats 
through the stimulation of adrenocortical activity by 
both synthesis and release of CORT (Chaudhuri-
Sengupta et al., 2003), the obtained result in our model 
with a high CORT and an increment in the adrenal 
cortex mass was as expected. It has been reported 
previously that lithium treatment increases the amount 
of blood GLU, but depletes the store of glycogen 
(Ghosh, 2007), suggesting that lithium probably affects 
the function of insulin (Fontela et al., 1986) which is 
unable to convert more glycogen from glucose. 
Moreover, the actions of lithium could also be 
explained to be a direct effect on the phosphorylation 
state of some key enzymes (like glycogen synthase 
kinase 3) (Rodriguez-Gil et al., 2000; Bosch et al., 1986).  
Finally, we analyzed the effect of lithium admi-
nistered immediately prior to the daily restraint 
procedure, regarding both serum CORT and blood 
GLU. Even though in previously described combined 
treatment the CORT level was elevated in respect to 
control, it seemed that lithium attenuated HPA axis 
hyperactivity evoked solely by the restraint stress. 
Also, at the level of blood GLU, exposure to lithium 
disabled the effect of chronic restraint stress. 
Taken together the results of our study 
suggested that Li treatment counteracted at least in 
part the effects of chronic restraint regarding CORT 
elevation. The observed decrease in CORT caused 
by Li treatment of chronically stressed animals may 
also help to replenish exhausted glucose generating 
pools. Thus we concluded that Li, a widely used 
substance for the treatment of manic-depression, is 
an agent of choice which may help in the treatment 
of HPA hyperactivity.  
This could be just one of the possible expla-
nations for lithium’s beneficial effects on a dis-
turbed HPA system. On the other hand, among the 
numerous effects of lithium on intracellular targets, 
its stimulatory action on impaired energy gene-
ration by mitochondrial oxidative phosphorylation 
seems to be crucial for its therapeutic efficacy 
(Maurer et al., 2009; Shalbuyeva et al., 2007). 
However, the precise mechanism of lithium action 
demands further investigations. 
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У приказаној студији праћена је промена 
масе адреналних жлезда и адреналних кортекса, 
као и нивоа кортикостерона у серуму и глукозе у 
крви мужјака Wistar пацова који су излагани 
различитим третманима: хроничном (restraint) 
стресу, деловању литијума, као и хроничном 
стресу уз претходно третирање литијумом. Под 
деловањем сва три третмана запажена је хипер-
трофија адреналних жлезда и њихових кортекса. 
Код хроничног стреса, било да је примењен без 
или са претходним давањем литијума, значајно 
је повећан ниво кортикостерона, али није уоче-
на промена нивоа глукозе у односу на нетре-
тиране животиње. Код животиња третираних 
само литијумом примећено је поред пораста 
нивоа кортикостерона и повећање нивоа глу-
козе у крви. Циљ рада био је испитивање потен-
цијала литијума да модулише одговор на хро-
нични стрес преко промене нивоа глукозе у 
крви, што би могло да умањи штетне последице 
стреса на организам. На основу добијених резул-
тата може се закључити да литијум снижава 
повишени ниво кортикостерона и спречава пре-
комерно исцрпљивање организма током стреса. 
 
 
 
